,date,title,url
0,2010-03-08,上海医药复牌公告,/disclosure/listedinfo/announcement/c/2010-03-08/601607_20100308_1.pdf
1,2010-03-09,上海医药复牌提示性公告,/disclosure/listedinfo/announcement/c/2010-03-09/601607_20100309_1.pdf
2,2010-03-11,上海医药换股吸收合并、发行股份购买资产暨关联交易实施情况报告书,/disclosure/listedinfo/announcement/c/2010-03-11/601607_20100311_1.pdf
3,2010-03-16,上海医药三届十三次董事会决议暨召开2010年第一次临时股东大会公告,/disclosure/listedinfo/announcement/c/2010-03-16/601607_20100316_1.pdf
4,2010-03-16,上海医药三届六次监事会决议公告,/disclosure/listedinfo/announcement/c/2010-03-16/601607_20100316_2.pdf
5,2010-03-24,上海医药2010年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-03-24/601607_20100324_1.pdf
6,2010-04-01,上海医药第四届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-01/601607_20100401_3.pdf
7,2010-04-01,上海医药第四届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-01/601607_20100401_2.pdf
8,2010-04-01,上海医药2010年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-04-01/601607_20100401_1.pdf
9,2010-04-01,上海医药2010年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-04-01/601607_20100401_4.pdf
10,2010-04-02,上海医药监事会议事规则,/disclosure/listedinfo/announcement/c/2010-04-02/601607_20100402_3.pdf
11,2010-04-02,上海医药股东大会议事规则,/disclosure/listedinfo/announcement/c/2010-04-02/601607_20100402_1.pdf
12,2010-04-02,上海医药公司章程（2010修订）,/disclosure/listedinfo/announcement/c/2010-04-02/601607_20100402_g.pdf
13,2010-04-02,上海医药董事会议事规则,/disclosure/listedinfo/announcement/c/2010-04-02/601607_20100402_2.pdf
14,2010-04-03,上海医药第四届董事会第二次会议决议暨收购并增资控股广州中山医医药有限公司的公告,/disclosure/listedinfo/announcement/c/2010-04-03/601607_20100403_1.pdf
15,2010-04-13,上海医药关于公司名称变更及办公地址变更的公告,/disclosure/listedinfo/announcement/c/2010-04-13/601607_20100413_1.pdf
16,2010-04-14,上海医药关于附属企业减持深圳市康达尔（集团）股份有限公司股票的公告,/disclosure/listedinfo/announcement/c/2010-04-14/601607_20100414_1.pdf
17,2010-04-21,上海医药年报摘要,/disclosure/listedinfo/announcement/c/2010-04-21/601607_2009_nzy.pdf
18,2010-04-21,上海医药年报,/disclosure/listedinfo/announcement/c/2010-04-21/601607_2009_n.pdf
19,2010-04-21,上海医药关联方资金往来审核报告,/disclosure/listedinfo/announcement/c/2010-04-21/601607_20100421_3.pdf
20,2010-04-21,上海医药第四届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-21/601607_20100421_2.pdf
21,2010-04-21,上海医药第四届董事会第三次会议决议暨关于召开2009年度股东大会的公告,/disclosure/listedinfo/announcement/c/2010-04-21/601607_20100421_1.pdf
22,2010-04-28,上海医药第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-28/601607_2010_1.pdf
23,2010-04-28,上海医药第四届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-28/601607_20100428_1.pdf
24,2010-05-07,上海医药信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2010-05-07/601607_20100507_10.pdf
25,2010-05-07,上海医药内幕信息及知情人管理制度,/disclosure/listedinfo/announcement/c/2010-05-07/601607_20100507_9.pdf
26,2010-05-07,上海医药内部审计制度,/disclosure/listedinfo/announcement/c/2010-05-07/601607_20100507_8.pdf
27,2010-05-07,上海医药募集资金管理办法,/disclosure/listedinfo/announcement/c/2010-05-07/601607_20100507_7.pdf
28,2010-05-07,上海医药关联交易管理制度,/disclosure/listedinfo/announcement/c/2010-05-07/601607_20100507_6.pdf
29,2010-05-07,上海医药独立董事工作制度,/disclosure/listedinfo/announcement/c/2010-05-07/601607_20100507_5.pdf
30,2010-05-07,上海医药董事会薪酬与考核委员会实施细则,/disclosure/listedinfo/announcement/c/2010-05-07/601607_20100507_4.pdf
31,2010-05-07,上海医药董事会审计委员会实施细则,/disclosure/listedinfo/announcement/c/2010-05-07/601607_20100507_3.pdf
32,2010-05-07,上海医药财务管理制度,/disclosure/listedinfo/announcement/c/2010-05-07/601607_20100507_2.pdf
33,2010-05-07,上海医药2009年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-05-07/601607_20100507_1.pdf
34,2010-05-19,上海医药2009年度股东大会年会决议公告,/disclosure/listedinfo/announcement/c/2010-05-19/601607_20100519_1.pdf
35,2010-05-19,上海医药2009年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-05-19/601607_20100519_2.pdf
36,2010-06-08,上海医药第四届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2010-06-08/601607_20100608_1.pdf
37,2010-07-06,上海医药2009年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2010-07-06/601607_20100706_1.pdf
38,2010-08-05,上海医药第四届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2010-08-05/601607_20100805_1.pdf
39,2010-08-05,上海医药半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-05/601607_2010_zzy.pdf
40,2010-08-05,上海医药半年报,/disclosure/listedinfo/announcement/c/2010-08-05/601607_2010_z.pdf
41,2010-09-07,上海医药重大事项停牌公告,/disclosure/listedinfo/announcement/c/2010-09-07/601607_20100907_1.pdf
42,2010-09-09,上海医药关于召开2010年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-09-09/601607_20100909_2.pdf
43,2010-09-09,上海医药第四届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2010-09-09/601607_20100909_1.pdf
44,2010-09-16,上海医药关于召开2010年第二次临时股东大会再次通知公告,/disclosure/listedinfo/announcement/c/2010-09-16/601607_20100916_1.pdf
45,2010-09-18,上海医药长期投资项目管理制度,/disclosure/listedinfo/announcement/c/2010-09-18/601607_20100918_2.pdf
46,2010-09-18,上海医药2010年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-09-18/601607_20100918_1.pdf
47,2010-09-28,上海医药2010年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-09-28/601607_20100928_1.pdf
48,2010-09-28,上海医药2010年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-09-28/601607_20100928_2.pdf
49,2010-10-30,上海医药第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-30/601607_2010_3.pdf
50,2010-11-30,上海医药第四届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2010-11-30/601607_20101130_1.pdf
51,2010-12-07,上海医药关于继续增持China Health System Ltd.股权的公告,/disclosure/listedinfo/announcement/c/2010-12-07/601607_20101207_1.pdf
52,2010-12-15,上海医药收购资产暨关联交易公告,/disclosure/listedinfo/announcement/c/2010-12-15/601607_20101215_2.pdf
53,2010-12-15,上海医药董事会战略委员会实施细则,/disclosure/listedinfo/announcement/c/2010-12-15/601607_20101215_3.pdf
54,2010-12-15,上海医药第四届董事会第十次会议决议暨召开2010年第三次临时股东大会通知公告,/disclosure/listedinfo/announcement/c/2010-12-15/601607_20101215_1.pdf
55,2010-12-24,上海医药2010年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-12-24/601607_20101224_1.pdf
56,2010-12-29,上海医药关于发行H股股票并在香港上市进展情况的公告,/disclosure/listedinfo/announcement/c/2010-12-29/601607_20101229_1.pdf
57,2010-12-31,上海医药2010年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-12-31/601607_20101231_1.pdf
58,2010-12-31,上海医药2010年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-12-31/601607_20101231_2.pdf
59,2011-01-04,上海医药关于发行H股股票并在香港上市进展情况的公告,/disclosure/listedinfo/announcement/c/2011-01-04/601607_20110104_1.pdf
60,2011-01-13,上海医药关于收购China Health System Ltd.股权进展暨设立北京代表处的公告,/disclosure/listedinfo/announcement/c/2011-01-13/601607_20110113_1.pdf
61,2011-01-29,上海医药第四届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2011-01-29/601607_20110129_1.pdf
62,2011-02-24,上海医药关于与上海复旦张江生物医药股份有限公司签订创新药物研发战略合作协议的公告,/disclosure/listedinfo/announcement/c/2011-02-24/601607_20110224_1.pdf
63,2011-03-09,上海医药年报摘要,/disclosure/listedinfo/announcement/c/2011-03-09/601607_2010_nzy.pdf
64,2011-03-09,上海医药年报,/disclosure/listedinfo/announcement/c/2011-03-09/601607_2010_n.pdf
65,2011-03-09,上海医药关于2010年度公司内部控制的自我评估报告,/disclosure/listedinfo/announcement/c/2011-03-09/601607_20110309_4.pdf
66,2011-03-09,上海医药关于2010年度公司履行社会责任的报告,/disclosure/listedinfo/announcement/c/2011-03-09/601607_20110309_5.pdf
67,2011-03-09,上海医药第四届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-09/601607_20110309_2.pdf
68,2011-03-09,上海医药第四届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-09/601607_20110309_1.pdf
69,2011-03-09,上海医药担保管理制度,/disclosure/listedinfo/announcement/c/2011-03-09/601607_20110309_6.pdf
70,2011-03-09,上海医药2010年度关联方资金往来审核报告,/disclosure/listedinfo/announcement/c/2011-03-09/601607_20110309_3.pdf
71,2011-03-10,上海医药关于发行H股股票并在香港上市进展情况的公告,/disclosure/listedinfo/announcement/c/2011-03-10/601607_20110310_1.pdf
72,2011-03-14,上海医药关于发行H股股票并在香港上市进展情况的公告,/disclosure/listedinfo/announcement/c/2011-03-14/601607_20110314_1.pdf
73,2011-04-06,上海医药关于上海上实（集团）有限公司增持公司股份公告,/disclosure/listedinfo/announcement/c/2011-04-06/601607_20110406_1.pdf
74,2011-04-07,上海医药重大资产重组实施情况之独立财务顾问持续督导意见,/disclosure/listedinfo/announcement/c/2011-04-07/601607_20110407_2.pdf
75,2011-04-07,上海医药关于收购China Health System Ltd.股权进展的公告,/disclosure/listedinfo/announcement/c/2011-04-07/601607_20110407_1.pdf
76,2011-04-13,上海医药关于与跨国医药企业深化战略合作的公告,/disclosure/listedinfo/announcement/c/2011-04-13/601607_20110413_1.pdf
77,2011-04-13,上海医药关于发行H股股票并在香港上市进展情况的公告,/disclosure/listedinfo/announcement/c/2011-04-13/601607_20110413_2.pdf
78,2011-04-18,上海医药关于香港联交所审议本公司发行境外上市外资股申请的公告,/disclosure/listedinfo/announcement/c/2011-04-18/601607_20110418_2.pdf
79,2011-04-18,上海医药关于刊发H股发行网上预览资料集的公告,/disclosure/listedinfo/announcement/c/2011-04-18/601607_20110418_3.pdf
80,2011-04-18,上海医药关于2011年第一季度报告业绩预增的公告,/disclosure/listedinfo/announcement/c/2011-04-18/601607_20110418_1.pdf
81,2011-04-19,上海医药总裁办公会议事规则,/disclosure/listedinfo/announcement/c/2011-04-19/601607_20110419_3.pdf
82,2011-04-19,上海医药投资者关系管理制度,/disclosure/listedinfo/announcement/c/2011-04-19/601607_20110419_2.pdf
83,2011-04-19,上海医药第四届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-19/601607_20110419_1.pdf
84,2011-04-21,上海医药关于与中国邮政集团公司签订全面战略合作框架协议书的公告,/disclosure/listedinfo/announcement/c/2011-04-21/601607_20110421_2.pdf
85,2011-04-21,上海医药关于与辉瑞公司签订谅解备忘录的公告,/disclosure/listedinfo/announcement/c/2011-04-21/601607_20110421_1.pdf
86,2011-04-26,上海医药第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-26/601607_2011_1.pdf
87,2011-05-03,上海医药关于公司股票停牌的公告,/disclosure/listedinfo/announcement/c/2011-05-03/601607_20110503_1.pdf
88,2011-05-06,上海医药关于刊发H股招股说明书、H股发行价格区间及H股香港公开发售等相关事宜的公告,/disclosure/listedinfo/announcement/c/2011-05-06/601607_20110506_1.pdf
89,2011-05-16,上海医药关于境外上市外资股（H股）公开发行价格的公告,/disclosure/listedinfo/announcement/c/2011-05-16/601607_20110516_1.pdf
90,2011-05-17,上海医药四届十五次董事会决议公告,/disclosure/listedinfo/announcement/c/2011-05-17/601607_20110517_1.pdf
91,2011-05-17,上海医药董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2011-05-17/601607_20110517_2.pdf
92,2011-05-19,上海医药澄清公告,/disclosure/listedinfo/announcement/c/2011-05-19/601607_20110519_1.pdf
93,2011-05-20,上海医药关于境外上市外资股（H股）国有股减持的公告,/disclosure/listedinfo/announcement/c/2011-05-20/601607_20110520_1.pdf
94,2011-05-20,上海医药关于境外上市外资股（H股）挂牌并上市交易的公告,/disclosure/listedinfo/announcement/c/2011-05-20/601607_20110520_2.pdf
95,2011-05-23,上海医药关于上海上实（集团）有限公司增持公司股份公告,/disclosure/listedinfo/announcement/c/2011-05-23/601607_20110523_1.pdf
96,2011-06-09,上海医药第四届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2011-06-09/601607_20110609_1.pdf
97,2011-06-10,上海医药关于召开2010年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-06-10/601607_20110610_1.pdf
98,2011-06-10,上海医药2010年度股东大会年会会议资料,/disclosure/listedinfo/announcement/c/2011-06-10/601607_20110610_2.pdf
99,2011-06-13,上海医药关于部分行使超额配售权、稳定价格行动及稳定价格期间结束的公告,/disclosure/listedinfo/announcement/c/2011-06-13/601607_20110613_1.pdf
100,2011-06-17,上海医药关于境外上市外资股（H股）行使超额配售权后的股份变动公告,/disclosure/listedinfo/announcement/c/2011-06-17/601607_20110617_1.pdf
101,2011-06-24,上海医药关于召开2010年度股东大会的第二次通知,/disclosure/listedinfo/announcement/c/2011-06-24/601607_20110624_1.pdf
102,2011-07-01,上海医药2010年度股东大会、2011年第一次H股类别股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-07-01/601607_20110701_1.pdf
103,2011-07-01,上海医药2010年度股东大会、2011年第一次H股类别股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-07-01/601607_20110701_2.pdf
104,2011-07-13,上海医药第四届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2011-07-13/601607_20110713_1.pdf
105,2011-08-15,上海医药关于2011年上半年度内部控制的自我评估报告,/disclosure/listedinfo/announcement/c/2011-08-15/601607_20110815_2.pdf
106,2011-08-15,上海医药第四届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-15/601607_20110815_1.pdf
107,2011-08-15,上海医药半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-15/601607_2011_zzy.pdf
108,2011-08-15,上海医药半年报,/disclosure/listedinfo/announcement/c/2011-08-15/601607_2011_z.pdf
109,2011-08-18,上海医药2010年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2011-08-18/601607_20110818_1.pdf
110,2011-08-22,上海医药关于高级管理人员购买本公司A股股票的公告,/disclosure/listedinfo/announcement/c/2011-08-22/601607_20110822_1.pdf
111,2011-08-25,上海医药关于上海上实（集团）有限公司增持公司股份的进展公告,/disclosure/listedinfo/announcement/c/2011-08-25/601607_20110825_1.pdf
112,2011-09-13,上海医药监事会议事规则（2011修订）,/disclosure/listedinfo/announcement/c/2011-09-13/601607_20110913_3.pdf
113,2011-09-13,上海医药股东大会议事规则（2011修订）,/disclosure/listedinfo/announcement/c/2011-09-13/601607_20110913_1.pdf
114,2011-09-13,上海医药公司章程（2011修订）,/disclosure/listedinfo/announcement/c/2011-09-13/601607_20110913_g.pdf
115,2011-09-13,上海医药董事会议事规则（2011修订）,/disclosure/listedinfo/announcement/c/2011-09-13/601607_20110913_2.pdf
116,2011-09-23,上海医药关于抗生素资产收购事宜进展及控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2011-09-23/601607_20110923_1.pdf
117,2011-10-28,上海医药重大资产重组限售股份上市流通提示性公告,/disclosure/listedinfo/announcement/c/2011-10-28/601607_20111028_2.pdf
118,2011-10-28,上海医药信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2011-10-28/601607_20111028_5.pdf
119,2011-10-28,上海医药关联（连）交易管理制度,/disclosure/listedinfo/announcement/c/2011-10-28/601607_20111028_4.pdf
120,2011-10-28,上海医药董事会审计委员会实施细则,/disclosure/listedinfo/announcement/c/2011-10-28/601607_20111028_3.pdf
121,2011-10-28,上海医药第四届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2011-10-28/601607_20111028_1.pdf
122,2011-10-28,上海医药第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-28/601607_2011_3.pdf
123,2011-10-29,上海医药关于2011年第三季度报告的更正公告,/disclosure/listedinfo/announcement/c/2011-10-29/601607_20111029_1.pdf
124,2011-10-29,上海医药第三季度季报（修订版）,/disclosure/listedinfo/announcement/c/2011-10-29/601607_2011_3.pdf
125,2011-12-01,上海医药关于公司副总裁葛剑秋先生辞呈的公告,/disclosure/listedinfo/announcement/c/2011-12-01/601607_20111201_1.pdf
126,2012-02-06,上海医药关于收购常州康丽制药有限公司100%股权的公告,/disclosure/listedinfo/announcement/c/2012-02-06/601607_20120206_1.pdf
127,2012-03-30,上海医药实际盈利数与利润预测数差异情况说明专项审核报告,/disclosure/listedinfo/announcement/c/2012-03-30/601607_20120330_5.pdf
128,2012-03-30,上海医药年报摘要,/disclosure/listedinfo/announcement/c/2012-03-30/601607_2011_nzy.pdf
129,2012-03-30,上海医药年报,/disclosure/listedinfo/announcement/c/2012-03-30/601607_2011_n.pdf
130,2012-03-30,上海医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2012-03-30/601607_20120330_6.pdf
131,2012-03-30,上海医药控股股东及其他关联方占用资金情况专项报告,/disclosure/listedinfo/announcement/c/2012-03-30/601607_20120330_3.pdf
132,2012-03-30,上海医药第四届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-30/601607_20120330_2.pdf
133,2012-03-30,上海医药第四届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-30/601607_20120330_1.pdf
134,2012-03-30,上海医药2011年内部控制评价报告,/disclosure/listedinfo/announcement/c/2012-03-30/601607_20120330_7.pdf
135,2012-03-30,上海医药2011年度社会责任报告,/disclosure/listedinfo/announcement/c/2012-03-30/601607_20120330_8.pdf
136,2012-03-30,上海医药2011年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2012-03-30/601607_20120330_4.pdf
137,2012-04-10,上海医药关于上海上实（集团）有限公司及其一致行动人增持公司股份实施情况的公告,/disclosure/listedinfo/announcement/c/2012-04-10/601607_20120410_1.pdf
138,2012-04-10,上海医药更正公告,/disclosure/listedinfo/announcement/c/2012-04-10/601607_20120410_2.pdf
139,2012-04-12,上海医药关于2012年第一季度业绩预减的公告,/disclosure/listedinfo/announcement/c/2012-04-12/601607_20120412_1.pdf
140,2012-04-14,上海医药股东上海上实（集团）有限公司增持上海医药集团股份有限公司股份之专项核查意见,/disclosure/listedinfo/announcement/c/2012-04-14/601607_20120414_1.pdf
141,2012-04-27,上海医药董事会提名委员会实施细则,/disclosure/listedinfo/announcement/c/2012-04-27/601607_20120427_3.pdf
142,2012-04-27,上海医药第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-27/601607_2012_1.pdf
143,2012-04-27,上海医药第四届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-27/601607_20120427_2.pdf
144,2012-04-27,上海医药第四届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-27/601607_20120427_1.pdf
145,2012-05-02,上海医药关于召开2011年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-05-02/601607_20120502_1.pdf
146,2012-05-02,上海医药2011年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-05-02/601607_20120502_2.pdf
147,2012-05-11,上海医药股东上海医药（集团）有限公司关于在公司2010年重大资产重组中承诺涉及的土地房产问题的说明,/disclosure/listedinfo/announcement/c/2012-05-11/601607_20120511_2.pdf
148,2012-05-11,上海医药公告,/disclosure/listedinfo/announcement/c/2012-05-11/601607_20120511_1.pdf
149,2012-05-24,上海医药关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2012-05-24/601607_20120524_1.pdf
150,2012-05-25,上海医药再次澄清公告,/disclosure/listedinfo/announcement/c/2012-05-25/601607_20120525_1.pdf
151,2012-05-25,上海医药关于控股股东增持本公司股份的公告,/disclosure/listedinfo/announcement/c/2012-05-25/601607_20120525_2.pdf
152,2012-06-01,上海医药2011年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-06-01/601607_20120601_1.pdf
153,2012-06-01,上海医药2011年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-06-01/601607_20120601_2.pdf
154,2012-06-02,上海医药关于收到上海证券交易所《关于加强上海医药集团股份有限公司规范运作的监管工作函》的公告,/disclosure/listedinfo/announcement/c/2012-06-02/601607_20120602_3.pdf
155,2012-06-02,上海医药第四届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2012-06-02/601607_20120602_2.pdf
156,2012-06-02,上海医药第四届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2012-06-02/601607_20120602_1.pdf
157,2012-06-07,上海医药监事会议事规则,/disclosure/listedinfo/announcement/c/2012-06-07/601607_20120607_3.pdf
158,2012-06-07,上海医药股东大会议事规则,/disclosure/listedinfo/announcement/c/2012-06-07/601607_20120607_1.pdf
159,2012-06-07,上海医药公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-06-07/601607_20120607_g.pdf
160,2012-06-07,上海医药董事会议事规则,/disclosure/listedinfo/announcement/c/2012-06-07/601607_20120607_2.pdf
161,2012-06-09,上海医药H股公告,/disclosure/listedinfo/announcement/c/2012-06-09/601607_20120609_1.pdf
162,2012-07-13,上海医药2011年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2012-07-13/601607_20120713_1.pdf
163,2012-07-18,上海医药关于2011年度利润分配实施的再次通知,/disclosure/listedinfo/announcement/c/2012-07-18/601607_20120718_1.pdf
164,2012-07-28,上海医药重大资产重组实施情况之独立财务顾问持续督导意见,/disclosure/listedinfo/announcement/c/2012-07-28/601607_20120728_1.pdf
165,2012-08-22,上海医药关联交易公告,/disclosure/listedinfo/announcement/c/2012-08-22/601607_20120822_2.pdf
166,2012-08-22,上海医药董事会战略委员会实施细则,/disclosure/listedinfo/announcement/c/2012-08-22/601607_20120822_3.pdf
167,2012-08-22,上海医药第四届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-22/601607_20120822_1.pdf
168,2012-08-22,上海医药半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-22/601607_2012_zzy.pdf
169,2012-08-22,上海医药半年报,/disclosure/listedinfo/announcement/c/2012-08-22/601607_2012_z.pdf
170,2012-10-08,上海医药关于高级管理人员购买本公司A股股票的公告,/disclosure/listedinfo/announcement/c/2012-10-08/601607_20121008_1.pdf
171,2012-10-09,上海医药第四届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2012-10-09/601607_20121009_1.pdf
172,2012-10-30,上海医药第四届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2012-10-30/601607_20121030_1.pdf
173,2012-10-30,上海医药第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-30/601607_2012_3.pdf
174,2012-10-31,上海医药关于上市公司股东、关联方以及上市公司承诺履行情况的公告,/disclosure/listedinfo/announcement/c/2012-10-31/601607_20121031_1.pdf
175,2013-02-05,上海医药限售股上市流通公告,/disclosure/listedinfo/announcement/c/2013-02-04/601607_20130205_1.pdf
176,2013-02-05,上海医药：中国国际金融有限公司关于上海医药集团股份有限公司重大资产重组非公开发行限售股份上市流通之核查意见,/disclosure/listedinfo/announcement/c/2013-02-04/601607_20130205_2.pdf
177,2013-03-13,上海医药拟收购杭州市正大青春宝职工持股会持有正大青春宝药业有限公司20%股权评估报告签署页,/disclosure/listedinfo/announcement/c/2013-03-12/601607_20130313_4.pdf
178,2013-03-13,上海医药拟收购杭州市正大青春宝职工持股会持有正大青春宝药业有限公司20%股权评估报告,/disclosure/listedinfo/announcement/c/2013-03-12/601607_20130313_3.pdf
179,2013-03-13,上海医药关于收购正大青春宝药业有限公司20%股权的关连/关联交易公告,/disclosure/listedinfo/announcement/c/2013-03-12/601607_20130313_2.pdf
180,2013-03-13,上海医药第四届董事会第二十六次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-12/601607_20130313_1.pdf
181,2013-03-27,上海医药实际盈利数与利润预测数差异情况说明专项审核报告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_18.pdf
182,2013-03-27,上海医药审计报告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_13.pdf
183,2013-03-27,上海医药年报摘要,/disclosure/listedinfo/announcement/c/2013-03-26/601607_2012_nzy.pdf
184,2013-03-27,上海医药年报,/disclosure/listedinfo/announcement/c/2013-03-26/601607_2012_n.pdf
185,2013-03-27,上海医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_16.pdf
186,2013-03-27,上海医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_17.pdf
187,2013-03-27,上海医药控股股东及其他关联方占用资金情况专项报告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_15.pdf
188,2013-03-27,上海医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_5.pdf
189,2013-03-27,上海医药独立董事关于2012年度担保事项的专项说明及独立意见签字页,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_12.pdf
190,2013-03-27,上海医药独立董事关于2012年度担保事项的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_11.pdf
191,2013-03-27,上海医药第四届监事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_3.pdf
192,2013-03-27,上海医药第四届董事会第二十七次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_2.pdf
193,2013-03-27,上海医药2013年度日常关联交易公告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_4.pdf
194,2013-03-27,上海医药2012年度社会责任报告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_10.pdf
195,2013-03-27,上海医药2012年度公司内部控制的自我评估报告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_9.pdf
196,2013-03-27,上海医药2012年度独立董事述职报告签字页,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_8.pdf
197,2013-03-27,上海医药2012年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_7.pdf
198,2013-03-27,上海医药2012年度财务报表及审计报告,/disclosure/listedinfo/announcement/c/2013-03-26/601607_20130327_14.pdf
199,2013-03-28,上海医药董事会薪酬与考核委员会实施细则,/disclosure/listedinfo/announcement/c/2013-03-27/601607_20130328_1.pdf
200,2013-04-09,上海医药第四届董事会第二十八次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-08/601607_20130409_1.pdf
201,2013-04-27,上海医药关于召开2012年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-04-26/601607_20130427_5.pdf
202,2013-04-27,上海医药第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-26/601607_2013_1.pdf
203,2013-04-27,上海医药第四届监事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-26/601607_20130427_4.pdf
204,2013-04-27,上海医药第四届董事会第二十九次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-26/601607_20130427_3.pdf
205,2013-04-27,上海医药2012年度股东大会会议文件,/disclosure/listedinfo/announcement/c/2013-04-26/601607_20130427_1.pdf
206,2013-05-11,上海医药关于高级管理人员购买本公司A股股票的公告,/disclosure/listedinfo/announcement/c/2013-05-10/601607_20130511_1.pdf
207,2013-05-17,上海医药关于投资设立上海实业集团财务有限公司的关连/关联交易公告,/disclosure/listedinfo/announcement/c/2013-05-16/601607_20130517_1.pdf
208,2013-05-25,上海医药关于控股股东及其一致行动人增持公司股份实施情况的公告,/disclosure/listedinfo/announcement/c/2013-05-24/601607_20130525_1.pdf
209,2013-05-25,上海医药：国浩律师（上海）事务所关于上海实业（集团）有限公司及其一致行动人增持上海医药集团股份有限公司股份之专项核查意见,/disclosure/listedinfo/announcement/c/2013-05-24/601607_20130525_2.pdf
210,2013-05-29,上海医药关于召开2012年度股东大会的第二次通知,/disclosure/listedinfo/announcement/c/2013-05-28/601607_20130529_1.pdf
211,2013-06-06,上海医药公司章程（2013修订）,/disclosure/listedinfo/announcement/c/2013-06-05/601607_20130606_6.pdf
212,2013-06-06,上海医药第五届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-05/601607_20130606_3.pdf
213,2013-06-06,上海医药第五届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-05/601607_20130606_2.pdf
214,2013-06-06,上海医药2012年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-06-05/601607_20130606_1.pdf
215,2013-06-06,上海医药2012年度股东大会的法律意见书（签字页）,/disclosure/listedinfo/announcement/c/2013-06-05/601607_20130606_5.pdf
216,2013-06-06,上海医药2012年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-06-05/601607_20130606_4.pdf
217,2013-06-25,上海医药关于上海第一生化药业有限公司收购Mergen Biotech Limited少数股权的关连/关联交易公告,/disclosure/listedinfo/announcement/c/2013-06-24/601607_20130625_1.pdf
218,2013-06-29,上海医药关于收购东英（江苏）药业有限公司79%股权的公告,/disclosure/listedinfo/announcement/c/2013-06-28/601607_20130629_1.pdf
219,2013-07-06,上海医药关于部分董事、监事、高级管理人员增持本公司A股股票的公告,/disclosure/listedinfo/announcement/c/2013-07-05/601607_20130706_1.pdf
220,2013-07-13,上海医药关于部分董事、高级管理人员增持本公司A股股票的公告,/disclosure/listedinfo/announcement/c/2013-07-12/601607_20130713_1.pdf
221,2013-07-18,上海医药2012年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2013-07-17/601607_20130718_1.pdf
222,2013-08-23,上海医药内幕信息及知情人管理制度,/disclosure/listedinfo/announcement/c/2013-08-22/601607_20130823_4.pdf
223,2013-08-23,上海医药第五届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-22/601607_20130823_2.pdf
224,2013-08-23,上海医药第五届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-22/601607_20130823_1.pdf
225,2013-08-23,上海医药半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-22/601607_2013_zzy.pdf
226,2013-08-23,上海医药半年报,/disclosure/listedinfo/announcement/c/2013-08-22/601607_2013_z.pdf
227,2013-09-24,上海医药关于部分高级管理人员增持本公司A股股票的公告,/disclosure/listedinfo/announcement/c/2013-09-23/601607_20130924_1.pdf
228,2013-10-26,上海医药拟转让其持有的中国国际医药（控股）有限公司股权的评估报告,/disclosure/listedinfo/announcement/c/2013-10-25/601607_20131026_7.pdf
229,2013-10-26,上海医药关于与上海医药（集团）有限公司签订《商标使用许可合同》的持续关连交易/日常关联交易的公告,/disclosure/listedinfo/announcement/c/2013-10-25/601607_20131026_4.pdf
230,2013-10-26,上海医药关于收购中国国际医药（控股）有限公司100%股权的关连/联交易公告,/disclosure/listedinfo/announcement/c/2013-10-25/601607_20131026_5.pdf
231,2013-10-26,上海医药第五届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-10-25/601607_20131026_3.pdf
232,2013-10-26,上海医药第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-25/601607_2013_3.pdf
233,2013-10-26,上海医药：评估报告签字页,/disclosure/listedinfo/announcement/c/2013-10-25/601607_20131026_8.pdf
234,2013-10-31,上海医药关于部分董事增持本公司A股股票的公告,/disclosure/listedinfo/announcement/c/2013-10-30/601607_20131031_1.pdf
235,2013-11-14,上海医药关于控股股东及其一致行动人股权结构变更的公告,/disclosure/listedinfo/announcement/c/2013-11-13/601607_20131114_1.pdf
236,2013-11-20,上海医药第五届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-11-19/601607_20131120_1.pdf
237,2013-12-03,上海医药拟收购上海交联药物研发有限公司全部股权项目涉及的上海交联药物研发有限公司股东全部权益价值评估报告（签字页）,/disclosure/listedinfo/announcement/c/2013-12-02/601607_20131203_3.pdf
238,2013-12-03,上海医药拟收购上海交联药物研发有限公司全部股权项目涉及的上海交联药物研发有限公司股东全部权益价值评估报告,/disclosure/listedinfo/announcement/c/2013-12-02/601607_20131203_2.pdf
239,2013-12-03,上海医药关于收购上海交联药物研发有限公司100%股权的关联交易公告,/disclosure/listedinfo/announcement/c/2013-12-02/601607_20131203_1.pdf
240,2013-12-03,上海医药：上海交联药物研发有限公司审计报告及财务报表,/disclosure/listedinfo/announcement/c/2013-12-02/601607_20131203_4.pdf
241,2013-12-30,上海医药关于部分高级管理人员增持本公司A股股票的公告,/disclosure/listedinfo/announcement/c/2013-12-29/601607_20131230_1.pdf
242,2014-02-15,上海医药关于实际控制人、股东、关联方、收购人以及公司承诺及履行情况公告,/disclosure/listedinfo/announcement/c/2014-02-14/601607_20140215_1.pdf
243,2014-02-15,上海医药：中国国际金融有限公司关于上海医药集团股份有限公司重大资产重组实际盈利数与利润预测数差异及补偿情况之核查意见,/disclosure/listedinfo/announcement/c/2014-02-14/601607_20140215_3.pdf
244,2014-03-29,上海医药年报摘要,/disclosure/listedinfo/announcement/c/2014-03-28/601607_2013_nzy.pdf
245,2014-03-29,上海医药年报,/disclosure/listedinfo/announcement/c/2014-03-28/601607_2013_n.pdf
246,2014-03-29,上海医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_9.pdf
247,2014-03-29,上海医药关于召开2013年度股东大会的通知,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_20.pdf
248,2014-03-29,上海医药关于与上海上实集团财务有限公司签订《金融服务框架协议》的关连/关联交易公告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_15.pdf
249,2014-03-29,上海医药关于上海医药（集团）有限公司变更关于土地房产承诺的议案,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_18.pdf
250,2014-03-29,上海医药关于上海医药（集团）有限公司变更关于内部职工股和职工持股会承诺的议案,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_14.pdf
251,2014-03-29,上海医药独立董事关于与上海上实集团财务有限公司签订《金融服务框架协议》暨关连/关联交易的独立意见,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_16.pdf
252,2014-03-29,上海医药独立董事关于公司2014年度日常关联交易的独立意见,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_13.pdf
253,2014-03-29,上海医药独立董事关于2013年度担保事项的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_3.pdf
254,2014-03-29,上海医药董事会审计委员会2013年度履职报告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_11.pdf
255,2014-03-29,上海医药第五届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_19.pdf
256,2014-03-29,上海医药第五届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_17.pdf
257,2014-03-29,上海医药承诺解决进展公告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_21.pdf
258,2014-03-29,上海医药：关于公司控股股东及其他关联方占用资金情况专项报告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_5.pdf
259,2014-03-29,上海医药2014年度日常关联交易公告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_12.pdf
260,2014-03-29,上海医药2013年度社会责任报告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_8.pdf
261,2014-03-29,上海医药2013年度公司内部控制的自我评估报告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_7.pdf
262,2014-03-29,上海医药2013年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_6.pdf
263,2014-03-29,上海医药2013年度财务报表及审计报告,/disclosure/listedinfo/announcement/c/2014-03-28/601607_20140329_4.pdf
264,2014-04-04,上海医药2013年度股东大会会议文件,/disclosure/listedinfo/announcement/c/2014-04-03/601607_20140404_1.pdf
265,2014-04-29,上海医药第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-28/601607_2014_1.pdf
266,2014-04-29,上海医药承诺解决进展公告,/disclosure/listedinfo/announcement/c/2014-04-28/601607_20140429_4.pdf
267,2014-04-30,上海医药关于召开2013年度股东大会的第二次通知,/disclosure/listedinfo/announcement/c/2014-04-29/601607_20140430_1.pdf
268,2014-05-08,上海医药关于控股股东增持本公司股份的公告,/disclosure/listedinfo/announcement/c/2014-05-07/601607_20140508_1.pdf
269,2014-05-09,上海医药2013年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-08/601607_20140509_1.pdf
270,2014-05-09,上海医药2013年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-05-08/601607_20140509_2.pdf
271,2014-05-20,上海医药2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-05-19/601607_20140520_2.pdf
272,2014-05-21,上海医药关于获得药品临床批件的公告,/disclosure/listedinfo/announcement/c/2014-05-20/601607_20140521_1.pdf
273,2014-05-23,上海医药澄清公告,/disclosure/listedinfo/announcement/c/2014-05-22/601607_20140523_1.pdf
274,2014-05-30,上海医药承诺解决进展公告,/disclosure/listedinfo/announcement/c/2014-05-29/601607_20140530_1.pdf
275,2014-06-04,上海医药关于八宝丹相关事宜的进展公告,/disclosure/listedinfo/announcement/c/2014-06-04/601607_20140604_1.pdf
276,2014-06-05,上海医药关于上海医疗器械股份有限公司转让工业包装耗材业务的关连/关联交易公告,/disclosure/listedinfo/announcement/c/2014-06-04/601607_20140605_1.pdf
277,2014-06-05,上海医药独立董事关于关联交易的独立意见,/disclosure/listedinfo/announcement/c/2014-06-04/601607_20140605_2.pdf
278,2014-06-12,上海医药关于合资成立研发公司的公告,/disclosure/listedinfo/announcement/c/2014-06-11/601607_20140612_1.pdf
279,2014-06-14,上海医药关于收购医药分销业务公司股权的公告,/disclosure/listedinfo/announcement/c/2014-06-13/601607_20140614_1.pdf
280,2014-06-14,上海医药：审计报告,/disclosure/listedinfo/announcement/c/2014-06-13/601607_20140614_3.pdf
281,2014-06-14,上海医药：评估报告,/disclosure/listedinfo/announcement/c/2014-06-13/601607_20140614_4.pdf
282,2014-06-14,上海医药：股权转让合同,/disclosure/listedinfo/announcement/c/2014-06-13/601607_20140614_2.pdf
283,2014-06-19,上海医药关于“八宝丹”相关事宜的进展公告,/disclosure/listedinfo/announcement/c/2014-06-18/601607_20140619_1.pdf
284,2014-06-24,上海医药关于收购山东地区医药分销企业股权的公告,/disclosure/listedinfo/announcement/c/2014-06-23/601607_20140624_1.pdf
285,2014-08-28,上海医药第五届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-27/601607_20140828_5.pdf
286,2014-08-28,上海医药第五届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-27/601607_20140828_4.pdf
287,2014-08-28,上海医药半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-27/601607_2014_zzy.pdf
288,2014-08-28,上海医药半年报,/disclosure/listedinfo/announcement/c/2014-08-27/601607_2014_z.pdf
289,2014-10-01,上海医药关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2014-09-30/601607_20141001_1.pdf
290,2014-10-30,上海医药关于执行新会计准则并对公司会计报表相关项目进行调整的公告,/disclosure/listedinfo/announcement/c/2014-10-29/601607_20141030_4.pdf
291,2014-10-30,上海医药关于召开2014年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-10-29/601607_20141030_3.pdf
292,2014-10-30,上海医药第五届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-29/601607_20141030_5.pdf
293,2014-10-30,上海医药第五届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-29/601607_20141030_6.pdf
294,2014-10-30,上海医药第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-29/601607_2014_3.pdf
295,2014-10-30,上海医药2014年第一次临时股东大会会议文件,/disclosure/listedinfo/announcement/c/2014-10-29/601607_20141030_7.pdf
296,2014-12-09,上海医药关于召开2014年第一次临时股东大会的第二次通知,/disclosure/listedinfo/announcement/c/2014-12-08/601607_20141209_1.pdf
297,2014-12-17,上海医药第五届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-16/601607_20141217_3.pdf
298,2014-12-17,上海医药2014年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-12-16/601607_20141217_1.pdf
299,2014-12-17,上海医药2014年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-12-16/601607_20141217_2.pdf
300,2014-12-30,上海医药关于收购医疗器械业务公司股权的公告,/disclosure/listedinfo/announcement/c/2014-12-29/601607_20141230_2.pdf
301,2014-12-30,上海医药关于聘任公司证券事务代表的公告,/disclosure/listedinfo/announcement/c/2014-12-29/601607_20141230_1.pdf
302,2015-01-27,上海医药关于下属企业获得国家科学技术进步奖一等奖的公告,/disclosure/listedinfo/announcement/c/2015-01-26/601607_20150127_1.pdf
303,2015-02-26,上海医药关于重组大理中谷红豆杉生物有限公司的公告,/disclosure/listedinfo/announcement/c/2015-02-25/601607_20150226_1.pdf
304,2015-02-28,上海医药关于重组大理中谷红豆杉生物有限公司的补充公告,/disclosure/listedinfo/announcement/c/2015-02-27/601607_20150228_1.pdf
305,2015-03-10,上海医药对外投资设立子公司的关联/关连交易公告,/disclosure/listedinfo/announcement/c/2015-03-09/601607_20150310_1.pdf
306,2015-03-10,上海医药第五届董事会第十三次会议独立董事关于关联交易的独立意见,/disclosure/listedinfo/announcement/c/2015-03-09/601607_20150310_2.pdf
307,2015-03-19,上海医药涉及诉讼公告,/disclosure/listedinfo/announcement/c/2015-03-18/601607_20150319_1.pdf
308,2015-03-27,上海医药债券发行预案公告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_7.pdf
309,2015-03-27,上海医药年报摘要,/disclosure/listedinfo/announcement/c/2015-03-26/601607_2014_nzy.pdf
310,2015-03-27,上海医药年报,/disclosure/listedinfo/announcement/c/2015-03-26/601607_2014_n.pdf
311,2015-03-27,上海医药监事会关于会计估计变更的说明,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_19.pdf
312,2015-03-27,上海医药会计估计变更公告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_3.pdf
313,2015-03-27,上海医药关于与上海上实集团财务有限公司续签《金融服务协议》暨关连/关联交易的公告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_5.pdf
314,2015-03-27,上海医药关于拟发行债务融资产品的公告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_6.pdf
315,2015-03-27,上海医药独立董事关于与上海上实集团财务有限公司签订《金融服务协议》暨关联/关联交易的独立意见,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_10.pdf
316,2015-03-27,上海医药独立董事关于公司2015年度日常关联交易的独立意见,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_9.pdf
317,2015-03-27,上海医药独立董事关于2014年度担保事项的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_12.pdf
318,2015-03-27,上海医药董事会审计委员会2014年度履职情况报告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_22.pdf
319,2015-03-27,上海医药董事会关于会计估计变更的说明,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_17.pdf
320,2015-03-27,上海医药第五届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_2.pdf
321,2015-03-27,上海医药第五届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_1.pdf
322,2015-03-27,上海医药：关于公司控股股东及其他关联方占用资金情况专项报告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_14.pdf
323,2015-03-27,上海医药：关于公司2014年度会计政策及会计估计变更的专项报告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_20.pdf
324,2015-03-27,上海医药2015年度日常关联交易公告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_4.pdf
325,2015-03-27,上海医药2014年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_18.pdf
326,2015-03-27,上海医药2014年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_21.pdf
327,2015-03-27,上海医药2014年度公司内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_16.pdf
328,2015-03-27,上海医药2014年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_15.pdf
329,2015-03-27,上海医药2014年度财务报表及审计报告,/disclosure/listedinfo/announcement/c/2015-03-26/601607_20150327_13.pdf
330,2015-04-02,上海医药关于2015年度担保计划的公告,/disclosure/listedinfo/announcement/c/2015-04-01/601607_20150402_1.pdf
331,2015-04-03,上海医药关于第五届董事会第十四次会议决议公告的补充公告,/disclosure/listedinfo/announcement/c/2015-04-02/601607_20150403_1.pdf
332,2015-04-10,上海医药关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-04-09/601607_20150410_1.pdf
333,2015-04-10,上海医药2014年度股东大会会议文件,/disclosure/listedinfo/announcement/c/2015-04-09/601607_20150410_2.pdf
334,2015-04-29,上海医药第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-28/601607_2015_1.pdf
335,2015-05-06,上海医药关于控股股东增持公司股份实施期限届满的公告,/disclosure/listedinfo/announcement/c/2015-05-05/601607_20150506_1.pdf
336,2015-05-06,上海医药：国浩律师（上海）事务所关于上海实业（集团）有限公司及其一致行动人增持上海医药集团股份有限公司股份之专项核查意见,/disclosure/listedinfo/announcement/c/2015-05-05/601607_20150506_2.pdf
337,2015-05-18,上海医药关于与北京京东世纪贸易有限公司签订战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2015-05-17/601607_20150518_1.pdf
338,2015-05-22,上海医药关于召开2014年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-05-21/601607_20150522_1.pdf
339,2015-05-30,上海医药关于参股公司首次公开发行证券预案的公告,/disclosure/listedinfo/announcement/c/2015-05-29/601607_20150530_2.pdf
340,2015-05-30,上海医药2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-05-29/601607_20150530_1.pdf
341,2015-05-30,上海医药2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-05-29/601607_20150530_3.pdf
342,2015-06-15,上海医药2014年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2015-06-14/601607_20150615_1.pdf
343,2015-07-07,上海医药关于与万达信息股份有限公司签署战略合作协议的公告,/disclosure/listedinfo/announcement/c/2015-07-06/601607_20150707_1.pdf
344,2015-07-11,上海医药关于维护公司股价稳定的公告,/disclosure/listedinfo/announcement/c/2015-07-10/601607_20150711_1.pdf
345,2015-07-21,上海医药对外投资公告,/disclosure/listedinfo/announcement/c/2015-07-20/601607_20150721_1.pdf
346,2015-08-11,上海医药关于董事会秘书辞职的公告,/disclosure/listedinfo/announcement/c/2015-08-11/601607_20150811_2.pdf
347,2015-08-11,上海医药第五届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-11/601607_20150811_1.pdf
348,2015-08-19,上海医药关于与北京京东世纪贸易有限公司合作进展情况的公告,/disclosure/listedinfo/announcement/c/2015-08-19/601607_20150819_1.pdf
349,2015-08-21,上海医药关于重点产品培菲康获得加拿大卫生部临床准入的公告,/disclosure/listedinfo/announcement/c/2015-08-21/601607_20150821_1.pdf
350,2015-08-27,上海医药关于注册地址变更的公告,/disclosure/listedinfo/announcement/c/2015-08-27/601607_20150827_6.pdf
351,2015-08-27,上海医药关于与江西南华医药有限公司签订《日常关联交易框架协议》暨日常关联/持续关连交易的议案,/disclosure/listedinfo/announcement/c/2015-08-27/601607_20150827_3.pdf
352,2015-08-27,上海医药关于设立健康医疗产业投资基金及投资基金管理公司的关连交易公告,/disclosure/listedinfo/announcement/c/2015-08-27/601607_20150827_5.pdf
353,2015-08-27,上海医药关于调整2015年度日常关联/持续关连交易额度的公告,/disclosure/listedinfo/announcement/c/2015-08-27/601607_20150827_4.pdf
354,2015-08-27,上海医药独立董事关于与江西南华医药有限公司日常关联交易的独立意见,/disclosure/listedinfo/announcement/c/2015-08-27/601607_20150827_8.pdf
355,2015-08-27,上海医药独立董事关于设立医疗健康产业投资基金及投资基金管理公司暨关联交易的独立意见,/disclosure/listedinfo/announcement/c/2015-08-27/601607_20150827_10.pdf
356,2015-08-27,上海医药独立董事关于调整公司2015年度日常关联交易额度的独立意见,/disclosure/listedinfo/announcement/c/2015-08-27/601607_20150827_9.pdf
357,2015-08-27,上海医药第五届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-27/601607_20150827_2.pdf
358,2015-08-27,上海医药半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-27/601607_2015_zzy.pdf
359,2015-08-27,上海医药半年报,/disclosure/listedinfo/announcement/c/2015-08-27/601607_2015_z.pdf
360,2015-08-28,上海医药：上海瑞力股权结构图及瑞力创新基金出资结构图说明,/disclosure/listedinfo/announcement/c/2015-08-28/601607_20150828_1.pdf
361,2015-10-01,上海医药关于与观澜网络（杭州）有限公司签订战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2015-10-01/601607_20151001_1.pdf
362,2015-10-30,上海医药董事会审计委员会实施细则,/disclosure/listedinfo/announcement/c/2015-10-30/601607_20151030_3.pdf
363,2015-10-30,上海医药第五届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2015-10-30/601607_20151030_1.pdf
364,2015-10-30,上海医药第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-30/601607_2015_3.pdf
365,2015-11-12,上海医药关于增资辽宁省医药对外贸易有限公司的公告,/disclosure/listedinfo/announcement/c/2015-11-12/601607_20151112_1.pdf
366,2015-12-09,上海医药关于控股子公司常州制药厂有限公司阿司匹林缓释片注册申请不被批准情况的公告,/disclosure/listedinfo/announcement/c/2015-12-09/601607_20151209_1.pdf
367,2015-12-14,上海医药关于向合格投资者公开发行公司债券申请获得中国证监会核准批复的公告,/disclosure/listedinfo/announcement/c/2015-12-14/601607_20151214_1.pdf
368,2015-12-16,上海医药关于控股子公司撤回赛米司酮片注册申请的公告,/disclosure/listedinfo/announcement/c/2015-12-16/601607_20151216_1.pdf
369,2015-12-19,上海医药关于控股子公司撤回药品注册申请的公告,/disclosure/listedinfo/announcement/c/2015-12-19/601607_20151219_1.pdf
370,2015-12-30,上海医药关于下属控股子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2015-12-30/601607_20151230_1.pdf
371,2015-12-31,上海医药关于全资子公司上海中华药业有限公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2015-12-31/601607_20151231_1.pdf
372,2016-01-05,上海医药关于全资子公司上海上药信谊药厂有限公司获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-01-05/601607_20160105_1.pdf
373,2016-01-06,上海医药关于控股子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-01-06/601607_20160106_1.pdf
374,2016-01-09,上海医药关于设立健康医疗产业投资基金及投资基金管理公司关联/连交易的阶段性进展公告,/disclosure/listedinfo/announcement/c/2016-01-09/601607_20160109_1.pdf
375,2016-01-09,上海医药关于全资子公司上海市药材有限公司获得国家科学技术进步奖一等奖的公告,/disclosure/listedinfo/announcement/c/2016-01-09/601607_20160109_2.pdf
376,2016-01-12,上海医药关于全资子公司上海市药材有限公司获得国家科学技术进步奖一等奖的补充公告,/disclosure/listedinfo/announcement/c/2016-01-12/601607_20160112_1.pdf
377,2016-01-22,上海医药公开发行2016年公司债券（第一期）信用评级报告,/disclosure/listedinfo/announcement/c/2016-01-22/601607_20160122_4.pdf
378,2016-01-22,上海医药公开发行2016年公司债券（第一期）募集说明书摘要（面向合格投资者）,/disclosure/listedinfo/announcement/c/2016-01-22/601607_20160122_3.pdf
379,2016-01-22,上海医药公开发行2016年公司债券（第一期）募集说明书（面向合格投资者）,/disclosure/listedinfo/announcement/c/2016-01-22/601607_20160122_1.pdf
380,2016-01-22,上海医药公开发行2016年公司债券（第一期）发行公告（面向合格投资者）,/disclosure/listedinfo/announcement/c/2016-01-22/601607_20160122_2.pdf
381,2016-01-26,上海医药公开发行2016年公司债券（第一期）票面利率公告,/disclosure/listedinfo/announcement/c/2016-01-26/601607_20160126_1.pdf
382,2016-01-29,上海医药公开发行2016年公司债券（第一期）发行结果公告,/disclosure/listedinfo/announcement/c/2016-01-29/601607_20160129_1.pdf
383,2016-02-04,上海医药关于与上海上实集团财务有限公司续签《金融服务协议》暨关联/关连交易的公告,/disclosure/listedinfo/announcement/c/2016-02-04/601607_20160204_2.pdf
384,2016-02-04,上海医药独立董事关于与上海上实集团财务有限公司签订《金融服务协议》暨关联/关连交易的独立意见,/disclosure/listedinfo/announcement/c/2016-02-04/601607_20160204_3.pdf
385,2016-02-04,上海医药第五届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2016-02-04/601607_20160204_1.pdf
386,2016-03-02,上海医药关于控股子公司常州武新制药有限公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-03-02/601607_20160302_1.pdf
387,2016-03-08,上海医药关于委托中国证券登记结算有限责任公司上海分公司代理债券兑付兑息相关事宜的公告,/disclosure/listedinfo/announcement/c/2016-03-08/601607_20160308_2.pdf
388,2016-03-08,上海医药公开发行2016年公司债券（第一期）上市公告书（面向合格投资者）,/disclosure/listedinfo/announcement/c/2016-03-08/601607_20160308_1.pdf
389,2016-03-17,上海医药关于全资子公司上药东英（江苏）药业有限公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-03-17/601607_20160317_1.pdf
390,2016-03-19,上海医药年报摘要,/disclosure/listedinfo/announcement/c/2016-03-19/601607_2015_nzy.pdf
391,2016-03-19,上海医药年报,/disclosure/listedinfo/announcement/c/2016-03-19/601607_2015_n.pdf
392,2016-03-19,上海医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_17.pdf
393,2016-03-19,上海医药累积投票制实施细则（草案）,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_19.pdf
394,2016-03-19,上海医药关于与江西南华医药有限公司续签《日常关联交易框架协议》暨日常关联/持续关连交易的议案,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_5.pdf
395,2016-03-19,上海医药关于拟发行债务融资产品的公告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_7.pdf
396,2016-03-19,上海医药关于控股子公司上海医药大健康云商股份有限公司A+轮融资暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_9.pdf
397,2016-03-19,上海医药关于董事会审计委员会2015年度履职报告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_18.pdf
398,2016-03-19,上海医药关于参与设立上海联一投资中心（有限合伙）暨关联/关连交易的公告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_8.pdf
399,2016-03-19,上海医药关于2016年度担保计划的公告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_6.pdf
400,2016-03-19,上海医药独立董事关于2015年度担保事项的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_11.pdf
401,2016-03-19,上海医药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_20.pdf
402,2016-03-19,上海医药第五届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_3.pdf
403,2016-03-19,上海医药第五届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_28.pdf
404,2016-03-19,上海医药：关于上海医药集团股份有限公司控股股东及其他关联方占用资金情况专项报告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_13.pdf
405,2016-03-19,上海医药2016年度日常关联交易公告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_4.pdf
406,2016-03-19,上海医药2015企业社会责任报告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_16.pdf
407,2016-03-19,上海医药2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_15.pdf
408,2016-03-19,上海医药2015年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_14.pdf
409,2016-03-19,上海医药2015年度财务报表及审计报告,/disclosure/listedinfo/announcement/c/2016-03-19/601607_20160319_12.pdf
410,2016-03-23,上海医药关于第五届董事会第二十一次会议决议公告的补充公告,/disclosure/listedinfo/announcement/c/2016-03-23/601607_20160323_1.pdf
411,2016-03-29,上海医药关于公司临床试验申请获得受理的公告,/disclosure/listedinfo/announcement/c/2016-03-29/601607_20160329_1.pdf
412,2016-04-14,上海医药关于控股子公司获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-04-14/601607_20160414_1.pdf
413,2016-04-19,上海医药关于下属公司获得日内瓦国际发明展金奖的公告,/disclosure/listedinfo/announcement/c/2016-04-19/601607_20160419_1.pdf
414,2016-04-29,上海医药2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-29/601607_2016_1.pdf
415,2016-04-30,上海医药2016年一季度业绩发布会电话会议纪要,/disclosure/listedinfo/announcement/c/2016-04-30/601607_20160430_2.pdf
416,2016-04-30,上海医药2016年第一季度业绩发布会会议纪要公告,/disclosure/listedinfo/announcement/c/2016-04-30/601607_20160430_1.pdf
417,2016-05-07,上海医药关于选举职工代表监事的公告,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_3.pdf
418,2016-05-07,上海医药关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_4.pdf
419,2016-05-07,上海医药关于下属企业与日本株式会社津村成立合资公司的公告,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_6.pdf
420,2016-05-07,上海医药关于提名第六届董事会董事和选举第五届董事会董事长的独立意见,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_12.pdf
421,2016-05-07,上海医药关于控股子公司上海上药中西制药有限公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_7.pdf
422,2016-05-07,上海医药关于董事长辞职和选举新任董事长的公告,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_5.pdf
423,2016-05-07,上海医药公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_13.pdf
424,2016-05-07,上海医药独立董事提名人声明,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_14.pdf
425,2016-05-07,上海医药独立董事候选人声明（尹锦滔）,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_8.pdf
426,2016-05-07,上海医药独立董事候选人声明（谢祖墀）,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_9.pdf
427,2016-05-07,上海医药独立董事候选人声明（洪亮）,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_11.pdf
428,2016-05-07,上海医药独立董事候选人声明（蔡江南）,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_10.pdf
429,2016-05-07,上海医药第五届监事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_2.pdf
430,2016-05-07,上海医药第五届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-07/601607_20160507_15.pdf
431,2016-05-12,上海医药关于公司SPH3127获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-05-12/601607_20160512_1.pdf
432,2016-05-13,上海医药关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-05-13/601607_20160513_2.pdf
433,2016-05-13,上海医药关于与五家医药企业签署合作备忘录的公告,/disclosure/listedinfo/announcement/c/2016-05-13/601607_20160513_1.pdf
434,2016-05-13,上海医药2015年度股东大会会议文件,/disclosure/listedinfo/announcement/c/2016-05-13/601607_20160513_3.pdf
435,2016-05-14,上海医药关于下属常州制药厂有限公司获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-05-14/601607_20160514_1.pdf
436,2016-05-14,上海医药关于公司控股股东股份解除质押的公告,/disclosure/listedinfo/announcement/c/2016-05-14/601607_20160514_2.pdf
437,2016-05-17,上海医药关于2016年公司债券（第一期）跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2016-05-17/601607_20160517_1.pdf
438,2016-05-17,上海医药公开发行2016年公司债券（第一期）跟踪评级报告（2016）,/disclosure/listedinfo/announcement/c/2016-05-17/601607_20160517_2.pdf
439,2016-05-28,上海医药关于公司获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-05-28/601607_20160528_1.pdf
440,2016-06-16,上海医药关于丹酚酸A及其粉针获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-06-16/601607_20160616_1.pdf
441,2016-06-22,上海医药关于召开2015年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-06-22/601607_20160622_1.pdf
442,2016-06-22,上海医药关于全资子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-06-22/601607_20160622_2.pdf
443,2016-06-29,上海医药关于全资子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-06-29/601607_20160629_4.pdf
444,2016-06-29,上海医药公司章程及三会议事规则,/disclosure/listedinfo/announcement/c/2016-06-29/601607_20160629_6.pdf
445,2016-06-29,上海医药独立非执行董事关于聘任公司高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2016-06-29/601607_20160629_7.pdf
446,2016-06-29,上海医药第六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-06-29/601607_20160629_3.pdf
447,2016-06-29,上海医药第六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-06-29/601607_20160629_2.pdf
448,2016-06-29,上海医药2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-06-29/601607_20160629_1.pdf
449,2016-06-29,上海医药2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-06-29/601607_20160629_5.pdf
450,2016-06-30,上海医药公开发行2016年公司债券（第一期）受托管理事务报告（2015年度）,/disclosure/listedinfo/announcement/c/2016-06-30/601607_20160630_1.pdf
451,2016-07-06,上海医药关于控股子公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2016-07-06/601607_20160706_1.pdf
452,2016-07-12,上海医药A股2015年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2016-07-12/601607_20160712_1.pdf
453,2016-07-14,上海医药澄清公告,/disclosure/listedinfo/announcement/c/2016-07-14/601607_20160714_1.pdf
454,2016-07-27,上海医药关于控股子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-07-27/601607_20160727_1.pdf
455,2016-08-04,上海医药关于参与私有化Vitaco Holdings Limited交易的公告,/disclosure/listedinfo/announcement/c/2016-08-04/601607_20160804_1.pdf
456,2016-08-16,上海医药关于注射用重组抗HER2人源化单克隆抗体组合物临床试验申请获得受理的公告,/disclosure/listedinfo/announcement/c/2016-08-16/601607_20160816_1.pdf
457,2016-08-23,上海医药澄清公告,/disclosure/listedinfo/announcement/c/2016-08-23/601607_20160823_1.pdf
458,2016-08-26,上海医药信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2016-08-26/601607_20160826_11.pdf
459,2016-08-26,上海医药关于羧基麦芽糖铁和舒更葡糖钠获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-08-26/601607_20160826_6.pdf
460,2016-08-26,上海医药关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2016-08-26/601607_20160826_4.pdf
461,2016-08-26,上海医药关于全资子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-08-26/601607_20160826_5.pdf
462,2016-08-26,上海医药关于董事长辞职暨推举董事代行董事长职责的公告,/disclosure/listedinfo/announcement/c/2016-08-26/601607_20160826_3.pdf
463,2016-08-26,上海医药公司章程（草案）,/disclosure/listedinfo/announcement/c/2016-08-26/601607_20160826_9.pdf
464,2016-08-26,上海医药独立非执行董事关于提名第六届董事会非执行董事和聘任公司高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2016-08-26/601607_20160826_7.pdf
465,2016-08-26,上海医药第六届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-26/601607_20160826_2.pdf
466,2016-08-26,上海医药2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-26/601607_2016_zzy.pdf
467,2016-08-26,上海医药2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-26/601607_2016_z.pdf
468,2016-08-27,上海医药关于控股子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-08-27/601607_20160827_1.pdf
469,2016-09-01,上海医药关于重组抗CD20人源化单克隆抗体及拉考沙胺获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-09-01/601607_20160901_1.pdf
470,2016-09-02,上海医药关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-09-02/601607_20160902_1.pdf
471,2016-09-02,上海医药2016年第一次临时股东大会会议文件,/disclosure/listedinfo/announcement/c/2016-09-02/601607_20160902_2.pdf
472,2016-10-14,上海医药关于召开2016年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-10-14/601607_20161014_1.pdf
473,2016-10-21,上海医药公司章程,/disclosure/listedinfo/announcement/c/2016-10-21/601607_20161021_5.pdf
474,2016-10-21,上海医药公司章程,/disclosure/listedinfo/announcement/c/2016-10-21/601607_20161021_4.pdf
475,2016-10-21,上海医药第六届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-21/601607_20161021_2.pdf
476,2016-10-21,上海医药2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-10-21/601607_20161021_1.pdf
477,2016-10-21,上海医药2016年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-10-21/601607_20161021_3.pdf
478,2016-10-24,上海医药关于参与私有化Vitaco Holdings Limited交易的进展公告,/disclosure/listedinfo/announcement/c/2016-10-24/601607_20161024_1.pdf
479,2016-10-28,上海医药2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-28/601607_2016_3.pdf
480,2016-11-03,上海医药关于参与私有化Vitaco Holdings Limited交易的进展公告,/disclosure/listedinfo/announcement/c/2016-11-03/601607_20161103_1.pdf
481,2016-11-05,上海医药关于全资子公司两个原料药通过FDA认证的公告,/disclosure/listedinfo/announcement/c/2016-11-05/601607_20161105_2.pdf
482,2016-11-05,上海医药澄清公告,/disclosure/listedinfo/announcement/c/2016-11-05/601607_20161105_1.pdf
483,2016-11-10,上海医药关于瑞舒伐他汀钙片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2016-11-10/601607_20161110_1.pdf
484,2016-11-23,上海医药关于完成工商变更登记及“三证合一”的公告,/disclosure/listedinfo/announcement/c/2016-11-23/601607_20161123_1.pdf
485,2016-12-01,上海医药关于参与私有化Vitaco Holdings Limited交易的进展公告,/disclosure/listedinfo/announcement/c/2016-12-01/601607_20161201_1.pdf
486,2016-12-07,上海医药关于参与私有化Vitaco Holdings Limited交易的进展公告,/disclosure/listedinfo/announcement/c/2016-12-07/601607_20161207_1.pdf
487,2016-12-17,上海医药关于参与私有化Vitaco Holdings Limited交易的进展公告,/disclosure/listedinfo/announcement/c/2016-12-17/601607_20161217_1.pdf
488,2016-12-21,上海医药关于SPH1188-11获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-12-21/601607_20161221_1.pdf
489,2017-01-20,上海医药2016年公司债券（第一期）2017年付息公告,/disclosure/listedinfo/announcement/c/2017-01-20/601607_20170120_1.pdf
490,2017-02-18,上海医药关于控股子公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2017-02-18/601607_20170218_1.pdf
491,2017-02-23,上海医药澄清公告,/disclosure/listedinfo/announcement/c/2017-02-23/601607_20170223_1.pdf
492,2017-02-28,上海医药关于参与投资设立私募基金的公告,/disclosure/listedinfo/announcement/c/2017-02-28/601607_20170228_1.pdf
493,2017-03-11,上海医药澄清公告,/disclosure/listedinfo/announcement/c/2017-03-11/601607_20170311_1.pdf
494,2017-03-22,上海医药关于追认2016年度与江西南华医药有限公司日常关联/持续关连交易超额部分的公告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_4.pdf
495,2017-03-22,上海医药关于拟发行债务融资产品的公告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_6.pdf
496,2017-03-22,上海医药关于变更证券事务代表的公告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_8.pdf
497,2017-03-22,上海医药关于变更内部职工股和职工持股会承诺的公告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_7.pdf
498,2017-03-22,上海医药关于2017年度担保计划的公告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_5.pdf
499,2017-03-22,上海医药独立董事关于2016年度担保事项的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_13.pdf
500,2017-03-22,上海医药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_11.pdf
501,2017-03-22,上海医药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_10.pdf
502,2017-03-22,上海医药董事会审计委员会2016年度履职报告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_18.pdf
503,2017-03-22,上海医药第六届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_2.pdf
504,2017-03-22,上海医药第六届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_26.pdf
505,2017-03-22,上海医药：关于上海医药集团股份有限公司控股股东及其他关联方占用资金情况专项报告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_15.pdf
506,2017-03-22,上海医药：2016年度财务报表及审计报告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_14.pdf
507,2017-03-22,上海医药2017年度日常关联交易公告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_3.pdf
508,2017-03-22,上海医药2016企业社会责任报告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_17.pdf
509,2017-03-22,上海医药2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-03-22/601607_2016_nzy.pdf
510,2017-03-22,上海医药2016年年度报告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_2016_n.pdf
511,2017-03-22,上海医药2016年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2017-03-22/601607_20170322_16.pdf
512,2017-03-23,上海医药信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2017-03-23/601607_20170323_3.pdf
513,2017-03-23,上海医药关于提请股东大会给予董事会配发、发行、处理股份的一般性授权的公告,/disclosure/listedinfo/announcement/c/2017-03-23/601607_20170323_4.pdf
514,2017-03-23,上海医药关于全资子公司上药东英（江苏）药业有限公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-03-23/601607_20170323_6.pdf
515,2017-03-23,上海医药关于聘请会计师事务所的公告,/disclosure/listedinfo/announcement/c/2017-03-23/601607_20170323_5.pdf
516,2017-03-23,上海医药：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-03-23/601607_20170323_2.pdf
517,2017-03-23,上海医药2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-03-23/601607_20170323_1.pdf
518,2017-04-18,上海医药关于下属子公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2017-04-18/601607_20170418_1.pdf
519,2017-04-25,上海医药关于2016年公司债券（第一期）跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2017-04-25/601607_20170425_1.pdf
520,2017-04-25,上海医药公开发行2016年公司债券（第一期）跟踪评级报告（2017）,/disclosure/listedinfo/announcement/c/2017-04-25/601607_20170425_2.pdf
521,2017-04-28,上海医药关于修订房屋及生产设备租赁日常关联交易/持续关连交易协议的公告,/disclosure/listedinfo/announcement/c/2017-04-28/601607_20170428_3.pdf
522,2017-04-28,上海医药关于新增2017年度对外担保计划的公告,/disclosure/listedinfo/announcement/c/2017-04-28/601607_20170428_4.pdf
523,2017-04-28,上海医药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2017-04-28/601607_20170428_6.pdf
524,2017-04-28,上海医药第六届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-28/601607_20170428_2.pdf
525,2017-04-28,上海医药2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-28/601607_2017_1.pdf
526,2017-05-06,上海医药关于新增2017年度对外担保计划的进一步公告,/disclosure/listedinfo/announcement/c/2017-05-06/601607_20170506_1.pdf
527,2017-05-09,上海医药关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-05-09/601607_20170509_1.pdf
528,2017-05-09,上海医药2016年度股东大会会议文件,/disclosure/listedinfo/announcement/c/2017-05-09/601607_20170509_2.pdf
529,2017-05-17,上海医药澄清公告,/disclosure/listedinfo/announcement/c/2017-05-17/601607_20170517_1.pdf
530,2017-05-18,上海医药关于下属子公司获得丁酸氯维地平及其注射用乳剂临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-05-18/601607_20170518_1.pdf
531,2017-05-23,上海医药关于羟基雷公藤内酯醇片临床试验申报获得受理的公告,/disclosure/listedinfo/announcement/c/2017-05-23/601607_20170523_1.pdf
532,2017-06-15,上海医药关于召开2016年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-06-15/601607_20170615_2.pdf
533,2017-06-16,上海医药关于增资入股上实商业保理有限公司并与其签订《商业保理服务框架协议》暨关联/关连交易的公告,/disclosure/listedinfo/announcement/c/2017-06-16/601607_20170616_1.pdf
534,2017-06-16,上海医药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2017-06-16/601607_20170616_2.pdf
535,2017-06-16,上海医药第六届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-06-16/601607_20170616_3.pdf
536,2017-06-24,上海医药2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-24/601607_20170624_1.pdf
537,2017-06-24,上海医药2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-24/601607_20170624_2.pdf
538,2017-06-30,上海医药公开发行2016年公司债券（第一期）受托管理事务报告（2016年度）,/disclosure/listedinfo/announcement/c/2017-06-30/601607_20170630_1.pdf
539,2017-07-05,上海医药关于注射用重组抗HER2人源化单克隆抗体-MCC-DM1偶联剂临床试验申请获得受理的公告,/disclosure/listedinfo/announcement/c/2017-07-05/601607_20170705_1.pdf
540,2017-07-08,上海医药2016年年度A股权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-07-08/601607_20170708_1.pdf
541,2017-08-14,上海医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2017-08-14/601607_20170814_1.pdf
542,2017-08-26,上海医药关于SPH3348原料药及其片剂临床试验申请获得受理的公告,/disclosure/listedinfo/announcement/c/2017-08-26/601607_20170826_1.pdf
543,2017-08-29,上海医药2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-29/601607_2017_zzy.pdf
544,2017-08-29,上海医药2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-29/601607_2017_z.pdf
545,2017-10-12,上海医药关于注射用重组抗HER2人源化单克隆抗体组合物获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-10-12/601607_20171012_1.pdf
546,2017-10-19,上海医药关于媒体报道相关情况的说明,/disclosure/listedinfo/announcement/c/2017-10-19/601607_20171019_1.pdf
547,2017-10-31,上海医药章程（2017年修订草案）,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_8.pdf
548,2017-10-31,上海医药监事会说明,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_4.pdf
549,2017-10-31,上海医药监事会说明,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_11.pdf
550,2017-10-31,上海医药关于修订《公司章程》以及《董事会议事规则》的公告,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_7.pdf
551,2017-10-31,上海医药关于全资子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_14.pdf
552,2017-10-31,上海医药关于签订房屋租赁框架协议暨日常关联交易的公告,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_5.pdf
553,2017-10-31,上海医药关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_9.pdf
554,2017-10-31,上海医药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_6.pdf
555,2017-10-31,上海医药董事会说明,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_10.pdf
556,2017-10-31,上海医药董事会说明,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_3.pdf
557,2017-10-31,上海医药第六届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_13.pdf
558,2017-10-31,上海医药第六届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-31/601607_20171031_12.pdf
559,2017-10-31,上海医药2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-31/601607_2017_3.pdf
560,2017-11-03,上海医药下属全资子公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2017-11-03/601607_20171103_1.pdf
561,2017-11-04,上海医药下属控股子公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2017-11-04/601607_20171104_1.pdf
562,2017-11-09,上海医药下属控股子公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2017-11-09/601607_20171109_2.pdf
563,2017-11-11,上海医药下属控股子公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2017-11-11/601607_20171111_1.pdf
564,2017-11-15,"上海医药关于收购Cardinal Health （L） Co., Ltd股权的公告",/disclosure/listedinfo/announcement/c/2017-11-15/601607_20171115_1.pdf
565,2017-11-15,上海医药关于境外全资子公司向控股股东贷款的关联交易公告,/disclosure/listedinfo/announcement/c/2017-11-15/601607_20171115_2.pdf
566,2017-11-15,上海医药第六届董事会第十次会议及第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-15/601607_20171115_3.pdf
567,2017-12-01,上海医药关于全资子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-12-01/601607_20171201_1.pdf
568,2017-12-05,上海医药下属全资子公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2017-12-05/601607_20171205_1.pdf
569,2017-12-09,上海医药关于全资子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-12-09/601607_20171209_1.pdf
570,2017-12-20,上海医药关于转让上海华氏资产经营有限公司100%股权的关联交易的公告,/disclosure/listedinfo/announcement/c/2017-12-20/601607_20171220_1.pdf
571,2017-12-20,上海医药独立董事的独立意见,/disclosure/listedinfo/announcement/c/2017-12-20/601607_20171220_2.pdf
572,2017-12-20,上海医药第六届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-20/601607_20171220_3.pdf
573,2017-12-30,上海医药关于非公开发行境外上市外资股（H股）获得中国证券监督管理委员会核准的公告,/disclosure/listedinfo/announcement/c/2017-12-30/601607_20171230_1.pdf
574,2018-01-04,上海医药关于控股子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2018-01-04/601607_20180104_1.pdf
575,2018-01-10,上海医药关于子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2018-01-10/601607_20180110_1.pdf
576,2018-01-12,"上海医药关于收购 Cardinal Health （L） Co., Ltd 交易的进展公告",/disclosure/listedinfo/announcement/c/2018-01-12/601607_20180112_1.pdf
577,2018-01-19,上海医药关于根据一般授权配售新H股的公告,/disclosure/listedinfo/announcement/c/2018-01-19/601607_20180119_2.pdf
578,2018-01-19,上海医药2016年公司债券（第一期）2018年付息公告,/disclosure/listedinfo/announcement/c/2018-01-19/601607_20180119_1.pdf
579,2018-01-27,上海医药关于完成根据一般授权配售新H股的公告,/disclosure/listedinfo/announcement/c/2018-01-27/601607_20180127_1.pdf
580,2018-02-02,"上海医药关于收购 Cardinal Health（L）Co.,Ltd 交易完成的公告",/disclosure/listedinfo/announcement/c/2018-02-02/601607_20180202_1.pdf
